Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) FCF Margin (2022 - 2024)

Genelux (GNLX) posted FCF Margin of 54800.0% for Q1 2024, down 1882.55% on a QoQ basis from 2764.12% in Q1 2023, and down 5203588.0% year-over-year from N/an in Q2 2023.

Analysis

Genelux (GNLX) FCF Margin (2022 - 2024) Analysis & Trends

Genelux has reported FCF Margin for 3 years, with the latest figure at 54800.0% in Q1 2024.

  • On a quarterly basis, FCF Margin fell 5203588.0% year-over-year to 54800.0% in Q1 2024; TTM through Dec 2024 was 270112.5%, a 25758309.0% decrease from a year earlier, with the FY2025 full-year figure at 329975.0%, down 5986250.0% from the prior year.
  • FCF Margin was 54800.0% for Q1 2024 at Genelux, down from 2764.12% in the prior quarter.
  • The five-year high for FCF Margin was 2232.35% in Q4 2022, with the low at 54800.0% in Q1 2024.
  • Average FCF Margin over 3 years is 19932.16%, with a median of 2764.12% recorded in 2023.
  • The largest YoY upside for FCF Margin was 5203588 bps in 2024 against a maximum downside of 5203588 bps in 2024.
  • Over 3 years, FCF Margin stood at 2232.35% in 2022, then decreased by 24 bps to 2764.12% in 2023, then tumbled by 1883 bps to 54800.0% in 2024.
  • The last three FCF Margin figures came in at 54800.0% (Q1 2024), 2764.12% (Q1 2023), and 2232.35% (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.70%
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 44.00%
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 30.39%
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 13.35%
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -388.28%
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 22.62%
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 14.91%
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -18,629.40%
10 Genelux 108.17 Mn 108.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -54,800.00%
Mar 31, 2023 -2,764.12%
Dec 31, 2022 -2,232.35%